Insulated cold-pack shipping · Lot-traceable · Published certificates
Research use only
Research-use disclosure
NextGen products are sold strictly for laboratory research. By entering this catalog you confirm you are at least 21 years old and you agree to our terms, privacy policy, and the use of cookies.
Insulated cold-pack shipping · Lot-traceable · Published certificates
Research use only
Lot Reference
Z33-RT10
Laboratory reference material
In stock · ships from the US
Price per mg by vial size
Retatrutide (LY3437943) is a synthetic peptide triple agonist engineered to simultaneously activate the GLP-1, GIP, and glucagon (GCGR) receptors. In-vitro and preclinical research literature characterizes concurrent incretin-receptor signaling coupled to glucagon-receptor activation, a combination studied for its effects on glucose-dependent insulin secretion, hepatic lipid handling, and cellular energy expenditure in animal models.
Purity profile · 10mg
3 certificates are published for this compound — all are linked below.
Specification sheet
Certificates of analysis
10mg · 99.79% (BioRegen) →20mg · 99.85% (BioRegen) →50mg · 99.805% (Janoshik) →
Analysis
Identity by mass spectrometry and purity by HPLC on the published lot
Use
Research use only · non-human
Return policy
All sales final · defective-lot replacement only
Analytical-grade biochemical reference material supplied strictly for in-vitro laboratory research and development. Not a drug, food, dietary supplement, cosmetic, or medical device; not approved by the U.S. Food and Drug Administration; not for human or animal consumption, or for therapeutic, clinical, or diagnostic use, dosing, injection, ingestion, or administration of any kind. Sold only to qualified researchers aged 21 or older.